Latest News about ADVM
Recent news which mentions ADVM
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 05, 2024
From Benzinga
Tickers
ADVM
From InvestorPlace
From Benzinga
From Benzinga
Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study
July 17, 2024
From Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
From Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
July 17, 2024
From Benzinga
Tickers
ADVM
From InvestorPlace
From Benzinga
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
From Benzinga
Tickers
ADVM
From InvestorPlace
Turn Pocket Change into Profit: 3 Penny Stocks Ready to Pop
March 06, 2024
From InvestorPlace
Stocks on the Launchpad: The Next 3 Market Sensations
February 27, 2024
From InvestorPlace
Unleash Massive Returns With These 3 Top Penny Stocks
February 22, 2024
From InvestorPlace
From Benzinga
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 05, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 05, 2024
From Benzinga
Why Adverum Biotechnologies Stock Is Trading Higher
February 05, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 05, 2024
From Benzinga
Why Is Eye Disease-Focused Adverum Bio Stock Trading Higher Today?
November 06, 2023
From Benzinga
Over $14M Bet On Diversified Healthcare Trust? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
June 12, 2023
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 28, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 26, 2022
From Benzinga
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
From Benzinga
Adverum Commences Mid-Stage Chronic Eye Disorder Candidate Study
September 14, 2022
Tickers
ADVM
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.